Novo’s Awiqli Receives FDA Approval as the First and Only Once-Weekly Insulin for Children 10 Years of Age and Older with Type 2 Diabetes

Oct 27, 2026 - 07:00
 0  0
PLAINSBORO, N.J., Oct. 23, 2026 /PRNewswire/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Awiqli (insulin icodec-abae) injection 700 units/mL, the first once-weekly, long-acting basal insulin, as an...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0